RxDoctor Payments Data

Monique Searight

Psychiatric/Mental Health · Havertown, PANPI 1801306014

Payments from drug & device makers

$539in general payments, 2019–2025

Across 26 payments — averaging $20.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$186
  • Otsuka America Pharmaceutical, Inc.$106
  • Sunovion Pharmaceuticals Inc.$83
  • Noven Therapeutics, LLC$43
  • Indivior Inc.$43
  • Alkermes, Inc.$20
  • plus $58 from 4 others

What the payments were for

  • Food & beverage$49291%
  • Education$479%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$539 in reported general payments places this provider in the 50th percentile of 1,041 psychiatric/mental health providers in Pennsylvania.

See all psychiatric/mental health providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$118,080
Medicare patients
122
Services billed
1,601

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Abilify MaintenaAripiprazole23$66,551
Invega SustennaPaliperidone Palmitate13$41,816
RexultiBrexpiprazole25$40,485
Aripiprazole154$7,436
Clozapine165$7,234
Haloperidol103$2,581
Perphenazine48$2,554
Olanzapine144$1,537
Benztropine Mesylate141$1,451
Trazodone Hcl181$1,329
Haloperidol Decanoate33$1,325
Risperidone151$1,209
Paroxetine Hcl107$1,036
Oxcarbazepine52$1,003
Vilazodone Hcl12$953

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$106$107,03648 claims
Johnson & JohnsonInvega Sustenna$13$41,81613 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 1,041 psychiatric/mental health providers in Pennsylvania.

Other psychiatric/mental health in Havertown

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →